Flutafuranol F-18

N/A

Report date: 2025/11/24 11:49:31
NME

Base Information

Drug NameFlutafuranol F-18
Drug Alias NameNAV-4694[18F]-AZD4694[18F]-NAV4694AZD-4694
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsCognitive DysfunctionAlzheimer DiseaseDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCerveau Technologies IncYoung Blood InstituteMeilleur Technologies Inc +[6] 
Active IndicationsN/A
Inactive IndicationsCognitive DysfunctionAlzheimer DiseaseDementia

Other Information

ATC CodeN/A
Related LinksN/A